Benzinga | Oct 1, 2021 07:04AM EDT

Rosenblatt Downgrades Xylem to Hold, Lowers Price Target to $120

Rosenblatt analyst Scott Graham downgrades Xylem (NYSE:XYL) from Buy to Hold and lowers the price target from $140 to $120.